Beyond GLP-1: Other Weight Loss Drugs to Consider

If you've heard about GLP-1 medications like Wegovy or Mounjaro for weight loss and are wondering, "Are there other weight loss drugs besides GLP-1?" you're not alone. Many people seeking weight management solutions are exploring options beyond the popular GLP-1 class of drugs, whether due to cost, side effects, availability, or personal health considerations. This article cuts through the confusion to explain the actual alternatives available, how they differ from GLP-1 agonists, and what you should know before discussing options with your healthcare provider. Understanding these alternatives is crucial for making informed decisions about your health journey.

Clarifying the GLP-1 Confusion

First, it's essential to clarify a common misunderstanding: GLP-1 isn't a single drug—it's a class of medications. Drugs like semaglutide (Wegovy, Ozempic), liraglutide (Saxenda), and tirzepatide (Mounjaro) are all GLP-1 receptor agonists. People asking "are there other weight loss drugs besides GLP-1" often mean "are there weight loss drugs that aren't GLP-1 agonists?" The answer is yes, but they work through different mechanisms and aren't all approved specifically for weight loss.

Weight Loss Drugs Beyond the GLP-1 Class

While GLP-1 agonists dominate the current weight loss drug landscape, other options exist, though they often have different primary approvals or limitations. Here are the main categories:

1. Dual and Triple Agonists (Not Strictly GLP-1)

Drugs like tirzepatide (Mounjaro, Zepbound) are technically GLP-1 agonists but also activate GIP receptors, making them "dual agonists." They're not "besides GLP-1" but represent a more potent evolution within the class. No widely available "triple agonists" (GLP-1/GIP/Glucagon) are approved for weight loss yet, though research is active.

2. Appetite Suppressants (Central Nervous System Agents)

These work by affecting brain signals to reduce hunger. Examples include:

Phentermine (Adipex-P, Lomaira): A stimulant-like drug approved for short-term use (up to 12 weeks), often combined with other medications. It's less effective for long-term weight loss than GLP-1 drugs and carries cardiovascular risks.
Naltrexone/Bupropion (Contrave): Combines an opioid antagonist and an antidepressant. It works by reducing cravings and increasing energy. Approved for chronic weight management, but weight loss is typically modest (5-10% of body weight).

3. Gut-Targeted Medications

These act primarily in the digestive system:

Orlistat (Xenical, Alli): Inhibits fat absorption in the gut. Over-the-counter Alli is weaker than prescription Xenical. Weight loss is usually modest (5-10% over a year), and side effects like oily stools are common.

4. Older, Less Common Options

Some drugs with weight loss effects but limited use today:

Liraglutide (Saxenda): This is actually a GLP-1 agonist, not an alternative. It was approved specifically for weight loss at higher doses than used for diabetes.
Phenylpropanolamine (PPA): Banned in the U.S. for weight loss due to stroke risks; not an option.
Metformin: Primarily a diabetes drug. It may cause slight weight loss in some people but isn't approved for weight loss and is generally ineffective as a standalone weight management tool.

How These Alternatives Compare to GLP-1 Drugs

When considering "are there other weight loss drugs besides GLP-1," it's vital to compare effectiveness, safety, and suitability:

Effectiveness: GLP-1 agonists typically produce 10-15% weight loss on average. Naltrexone/bupropion averages 5-10%, orlistat 5-10%, and phentermine 5-7% (short-term). GLP-1 drugs generally outperform others for significant weight loss.
Side Effects: GLP-1 drugs commonly cause nausea (often temporary), diarrhea, and constipation. Appetite suppressants like phentermine can cause insomnia, increased heart rate, and anxiety. Orlistat causes gastrointestinal issues related to fat malabsorption.
Approval Status: Only Wegovy (semaglutide), Mounjaro (tirzepatide), and Saxenda (liraglutide) are FDA-approved specifically for chronic weight management. Contrave and orlistat have broader approvals but are less potent.

Who Might Consider Alternatives to GLP-1 Drugs?

Alternatives may be considered in specific scenarios:

GLP-1 Side Effects: If nausea or gastrointestinal issues are severe and unmanageable with GLP-1 drugs, a healthcare provider might suggest trying naltrexone/bupropion or orlistat.
Cost and Insurance: GLP-1 drugs are expensive and often require prior authorization. If insurance denies coverage, alternatives like orlistat (Alli) or phentermine (if covered) may be explored, though they're less effective.
Medical Conditions: GLP-1 drugs are generally avoided in people with a history of pancreatitis or certain thyroid cancers. Alternatives like orlistat or naltrexone/bupropion may be safer options in these cases.
Short-Term Goals: Phentermine is sometimes used for short-term weight loss (e.g., before surgery), but it's not ideal for long-term management.

Key Considerations Before Trying Any Weight Loss Drug

Regardless of the drug, these factors are critical:

Medical Supervision is Mandatory: All prescription weight loss drugs require a doctor's evaluation and ongoing monitoring. Never self-prescribe or share medications.
Not a Magic Pill: All weight loss drugs work best alongside diet, exercise, and behavioral changes. Expectations should be realistic—significant weight loss requires lifestyle integration.
Side Effects Vary: Discuss your full medical history with your provider to assess risks. For example, phentermine isn't safe for people with heart conditions.
Cost and Insurance: GLP-1 drugs often cost $800-$1,300 per month without insurance. Orlistat (Alli) is cheaper ($50-$100/month), and naltrexone/bupropion may be covered by some plans.

What You Should Know Before Discussing Alternatives with Your Doctor

When you ask "are there other weight loss drugs besides GLP-1," be prepared to discuss:

Your specific weight loss goals and history
Your current medications and health conditions (especially heart, kidney, or mental health issues)
Your tolerance for side effects
Your budget and insurance coverage
Your willingness to commit to lifestyle changes

Ask your provider: "What are the most effective options for my specific situation, considering my health history?" Avoid pressuring them for a specific drug—focus on finding the best fit for you.

Why GLP-1 Drugs Remain the Gold Standard for Many

Despite the search for alternatives, GLP-1 agonists dominate because they offer the most significant weight loss results with a manageable side effect profile for most people. Newer drugs like tirzepatide (Mounjaro/Zepbound) show even greater efficacy. For people who can access them safely and affordably, they're often the most effective starting point. Alternatives are generally reserved for when GLP-1 drugs aren't suitable, not as first-line options.

Future Developments in Weight Loss Medication

Research is ongoing for new options, including:

Glucagon-like peptide-1/glucagon receptor co-agonists (GLP-1/Glucagon): Early trials show potential for greater weight loss than GLP-1 alone, but none are approved yet.
Non-injectable options: Oral GLP-1 drugs (like oral semaglutide) are in development to improve accessibility.

For now, the landscape remains focused on GLP-1-based drugs and the limited alternatives discussed above.

How to Choose the Right Weight Loss Drug for You

There's no single "best" drug. The right choice depends on:

Your Health Profile: Existing conditions determine safety (e.g., avoid phentermine with hypertension).
Weight Loss Goals: For 15%+ loss, GLP-1 drugs are superior. For modest goals, alternatives may suffice.
Side Effect Tolerance: If nausea is a dealbreaker, discuss naltrexone/bupropion with your provider.
Practical Factors: Cost, insurance coverage, and injection preference (oral vs. injectable) matter.

Work with your healthcare provider to weigh these factors—not just the drug name. They'll consider your full picture to recommend the safest, most effective path.